Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds by Beatriz Lopes Columbano Marques de Almeida
  
Portuguese and 
Taiwanese 
Machado-Joseph 
disease haplotype 
backgrounds 
 
 Beatriz Lopes Columbano Marques Almeida 
Genética Forense 
Faculdade de Ciências 
2017 
 
Orientador  
Sandra Martins, PhD, i3S/ IPATIMUP 
 
ii |Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds 
 
  
 Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds| iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Todas as correções determinadas  
pelo júri, e só essas, foram efetuadas. 
 
O Presidente do Júri, 
 
 
Porto, ______/______/_________ 
iv |Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds 
 
  
 Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds| v 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Toda a conquista começa com a decisão de tentar” 
Gail Devers 
  
vi |Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds 
 
  
 Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds| vii 
 
Agradecimentos 
Foram várias as pessoas que, direta ou indiretamente, ajudaram na elaboração 
deste trabalho, às quais gostaria de agradecer. 
Ao Professor Amorim, pela disponibilidade e facilidades concedidas durante a 
realização deste trabalho. 
À minha orientadora, Sandra Martins, pela sua dedicação, paciência, sentido, 
crítico e rigor científico depositados no decorrer deste trabalho. 
Ao Centro de Genética Preditiva e Preventiva (CGPP) – i3S/IBMC, pela 
disponibilização das amostras. 
A todos os doentes e seus familiares que colaboraram neste estudo, dirijo um 
agradecimento especial. 
À Inês Costa por toda ajuda e amizade durante este último ano. 
Aos meus companheiros de casa e amigos, Margarida e António, por todo o 
apoio. 
Às minhas amigas, Bruna e Lara, por terem estado sempre disponíveis em 
qualquer momento e por sempre tornarem tudo melhor. 
Ao Ricardo, pelas palavras de carinho e positividade. 
Aos meus pais, por todo o apoio que sempre me deram, por todas as palavras 
de força e por tudo o que fazem por mim para que tudo seja possível. 
A todos, muito obrigada! 
 
  
viii |Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds 
 
  
 Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds| ix 
 
Abstract 
Machado-Joseph disease (MJD), also called spinocerebellar ataxia type 3 
(SCA3), is a late-onset neurodegenerative disorder with a very pleomorphic clinical 
presentation. Among all autosomal dominant SCAs, MJD is the most frequent 
worldwide, and it is associated with a (CAG)n expansion in the ATXN3 gene (14q24.3-
q32.1). Patients usually carry one allele harbouring between 61 and 87 CAGs while the 
range for normal tract is 12-44. Contrarily to other repeat-associated disorders, there is 
a marked gap between normal and expanded ranges in MJD, from 45 to 60 CAGs, with 
the role of intermediate alleles on disease pathogenesis still unclear. To date, the 
molecular mechanism often proposed as causative of repeat instability of both 
intermediate and expanded alleles is the aberrant replication of DNA due to the 
formation of unusual conformations. 
The analysis of MJD haplotypes defined by (CAG)n-flanking SNPs and STRs 
allowed the identification of two independent mutational events: the worldwide spread 
Joseph lineage (TTA-(CAG)exp-CAC) of Asian origin; and a more recent Machado 
lineage on the GTG-(CAG)exp-GCA background. The authors analysed stable SNP 
haplotype backgrounds, which allowed them to distinguish alleles identical-by-descent 
from alleles identical-by-state flanking the CAG repeat, essential if the phylogenetic 
relationships among (CAG)n alleles are to be determined. 
We now aimed at refining MJD haplotype studies to discern whether other 
independent-origin mutations may be underlying the previously identified MJD 
lineages. We extended the analysis to genotype a battery of 30 polymorphic markers 
(23 SNPs and 7 STRs) flanking the CAG repeat in 43 MJD families of Portuguese 
(n=21) and Taiwanese (n=22) origins. 
Nineteen of the 23 analysed SNPs distinguished the two main Machado and 
Joseph lineages. In eight families from Taiwan, the SNP rs56268847 further discerned 
a more recent common ancestor for a Joseph-derived haplotype, previously described 
by us, in Australian aborigines and other Asian families. Based on flanking markers, 
genetic diversity is higher among Asian Joseph-derived families than in the most 
common Joseph lineage, which led us to raise alternative hypotheses to the origins of 
MJD. Next, our analysed fast-evolving markers will allow us to estimate more 
accurately the age of mutations and time for their introduction in different populations. 
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In addition to the study of worldwide spread MJD mutations, our analyses are 
important to identify the most informative SNPs for allele-specific down-regulation of 
expanded alleles during siRNA therapies. 
 
Keywords: Neurodegenerative disorder, Machado-Joseph disease, ATXN3 gene, 
PCR optimization, SNP, STR, haplotype, origins. 
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Resumo 
A doença Machado-Joseph (DMJ), também designada por ataxia 
espinocerebelosa do tipo 3, é uma doença neurodegenerativa com início tardio e 
caracterizada por sintomas clínicos muito pleomórficos. Entre todas as ataxias 
espinocerebelosas autossómicas dominantes, a DMJ é a mais frequente em todo o 
mundo, e está associada a uma expansão de repetições do trinucleótido (CAG)n no 
gene ATXN3 (14q24.3-q32.1). Os doentes com DMJ são, normalmente, portadores de 
um alelo que contém entre 61 a 87 repetições, enquanto que os alelos normais 
possuem repetições entre 12 a 44 CAGs. Contrariamente a outras doenças 
associadas a repetições, existe um notório intervalo entre o número de repetições dos 
alelos normais e expandidos, entre os 45 e os 60 CAGs. O papel destes alelos 
intermédios na patogénese da DMJ continua ainda por determinar. Atualmente, o 
mecanismo molecular comummente proposto como causador da instabilidade nas 
repetições trinucleotídicas (em alelos intermédios e expandidos) é a replicação 
anormal do ADN, levando à formação de conformações invulgares. 
As análises dos haplótipos associados à DMJ definidos por SNPs e STRs que 
flanqueiam o (CAG)n permitiram identificar dois eventos mutacionais independentes: a 
linhagem Joseph, a mais comum no mundo (TTA-(CAG)exp-CAC) de origem asiática; e 
uma linhagem mais recente – Machado – com o haplótipo GTG-(CAG)exp-GCA. Assim, 
o uso de haplótipos estáveis de SNPs permitiram a distinção entre alelos idênticos-
por-descendência e alelos idênticos-por-estado, essencial para determinar as relações 
filogenéticas entre os alelos (CAG)n. 
Atualmente o nosso objetivo é melhorar os estudos haplotípicos associados à 
DMJ de forma a descobrir se outras mutações com origem independente poderão 
estar subjacentes às duas linhagens previamente identificadas. Assim, aumentamos a 
análise para genotipar 30 marcadores polimórficos (23 SNPs e 7 STRs) que falqueiam 
a região trinucleotídica (CAG)n em 43 famílias DMJ com origens Portuguesa (n=21) e 
Taiwanesa (n=22). 
Dezanove dos 23 SNPs analisados neste estudo distinguem as duas linhagens 
Machado e Joseph. Em 8 famílias de Taiwan, o SNP rs56268847 discerniu um 
ancestral comum mais recente para um haplótipo derivado da linhagem Joseph, 
anteriormente descrito pelo nosso grupo de investigação, em aborígenes australianos 
em outras famílias asiáticas. Através da análise de marcadores flanqueantes, a 
diversidade genética é maior nas famílias Asiáticas pertencentes à linhagem “Joseph-
derived” do que na linhagem Joseph mais comum, o que nos levou a formular novas 
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hipóteses para as origens mutacionais da DMJ. Posteriormente, esses marcadores de 
evolução rápida irão permitir que consigamos estimar com mais precisão a idade das 
mutações e o tempo decorrido até à introdução das mesmas em diferentes 
populações. 
Além do estudo das mutações associadas à DMJ em todo o mundo, as nossas 
análises serão importantes para identificar os SNPs mais informativos para o 
silenciamento específico de alelos expandidos durante a terapia génica usando a 
técnica associada ao siRNA. 
 
Palavras-chave: Doenças neurodegenerativas, doença Machado-Joseph, gene 
ATXN3, optimização de PCR, SNP, STR, haplótipos, origens. 
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Introduction 
1. Human Genomic Variation 
Over human evolution, the DNA has changed as a consequence of different 
types of mutations, which occur in the germ line and are, therefore, heritable. Due to 
the high fidelity of DNA polymerases and DNA repair mechanisms, these mutations 
occur at low rates, still inevitable in every generation, which justify the current genetic 
diversity observed among individuals. On the other hand, meiotic recombination 
generates new combinations of allelic states from different polymorphic sites, resulting 
in new haplotypes, which consequently increase the genetic diversity among 
populations (Jobling et al. 2014). This way, genetic diversity represents the total 
genomic variation among individuals within a population (Barrandeguy & García 2014). 
Human genetic diversity has been studied since blood groups were discovered 
(Landsteiner 1900). Early methods for studying this diversity were indirect, based on 
immunological reactions and electrophoretic analysis of gene products. Later, 
approaches evolved toward the direct detection of DNA variation. Some technological 
advances have further increased the pace of diversity studies, such as: i) the 
development of capillary DNA sequencing; ii) the subsequent determination of the 
human genome reference sequence; iii) precise methods for high-throughput genome-
wide single nucleotide polymorphism (SNP) typing; iv) consistent methods for the 
measurement of structural and copy-number variation; and, v) the development of next-
generation and third-generation sequencing (Jobling et al. 2014). 
Several measures of genetic diversity have been developed over the years 
(Barrandeguy & García 2014). Perhaps the simplest way to describe the amount of 
diversity is to count the number of haplotypes present. This can be done either within 
many populations for a single locus, allowing a comparison of diversity between 
populations, or at many loci within a single population, allowing a comparison among 
loci (Jobling et al. 2014). 
The Nei’s gene diversity statistic is normally used to measure genetic diversity 
observed among members of a population (Nei 1987; Jobling et al. 2014). If we 
consider that a certain genetic locus has K distinct alleles, with positive frequencies P1, 
P2, …PK, then ∑ Pi=1ki=1 , and the gene diversity at this locus is defined by 
H=1-∑P2i
K
i=1
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Thus, H is the probability that two members, randomly chosen from a population, 
will show different genetic alleles at a specific site in the genome (Kang 2015). 
Consequently, for diploid loci this statistic is referred to as a measure of heterozygosity 
(Jobling et al. 2014). 
The genetic diversity, generated as a consequence of mutations, is the ultimate 
source of variation for the long-term evolution of organisms, an important parameter in 
evolutionary biology, which provides perception into the demographic history of human 
populations (Osada 2015). Additionally, the study of human genetic diversity is 
essential to understand the mutational mechanisms and disease susceptibility at both 
population and individual levels (Lu et al. 2014; Osada 2015). 
 
2. Molecular Markers 
A molecular marker is a nucleotide sequence corresponding to a particular known 
or unknown physical location in the genome, which allows to obtain information of 
genetic diversity and also differentiation of individuals at the DNA level (Barrandeguy & 
García 2014). In less than half a century, molecular markers have totally changed our 
view of biology because of their ability to differentiate two or more genotypes 
(Schlotterer 2004; Grover & Sharma 2014). Also, in the last decades, progress in 
molecular biology has increased the capacity to detect molecular genetic markers. The 
ease of handling DNA markers improved substantially with the development of 
techniques based on nucleic acid hybridization, polymerase chain reaction (PCR) and 
DNA sequencing (Grover & Sharma 2014). These molecular markers have been 
analysed to answer many biological questions, ranging from gene mapping to 
population genetics, phylogenetic reconstruction, paternity testing and forensic 
applications (Schlotterer 2004). 
The first true molecular markers to be established were allozymes since 
previously, various factors restricted the use of secondary metabolites as a marker due 
to their instability (Grover & Sharma 2014). The principle behind allozymes is based on 
protein variants distinguished by native gel electrophoresis. However, allozymes were 
an indirect and insensitive method to detect variation in DNA and, for this reason, the 
arrival of DNA manipulation techniques promoted a shift from enzyme-based to DNA-
based markers (Schlotterer 2004). The discovery of restriction fragment length 
polymorphism (RFLPs) improved the analysis of non-coding sequences, and the 
survey of changes in coding sequence, contributing also to the first DNA-based genetic 
maps (Vignal et al. 2002; Schlotterer 2004). Later, the extremely high polymorphic level 
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of minisatellites revolutionized the genetic identification of individuals with the 
technique of DNA fingerprinting. In 1988, the invention of PCR improved the PCR-
based markers, such as random amplified polymorphic DNA (RAPDs), inter-simple 
sequence repeats (ISSRs), inter-retrotransposon amplified polymorphisms (IRAPs), 
amplified fragment length polymorphisms (AFLPs) and microsatellites. These 
molecular markers allowed the amplification and analysis of virtually all genomic 
regions (Schlotterer 2004). Therefore, PCR, as well as fluorescent sequencing and 
fragment analysis technologies, have catalysed a revolution in the development of 
genetic markers for the analysis of populations (Brumfield et al. 2003). The latest major 
innovation in detecting genetic variation in populations was the analysis and 
identification of SNPs (Goodwin et al. 2011). More recently, advances in next 
generation sequencing (NGS) technologies have contributed towards high throughput 
discovery of even larger numbers of SNPs, revolutionizing again genetic diversity 
assessment projects and genome-wide association studies (GWAS) (Grover & Sharma 
2014). 
 
2.1 Microsatellites 
Short Tandem Repeats (STRs, also called microsatellites) are a class of simple 
repetitive DNA sequences composed of small motifs between 1 and 7 nucleotides 
repeated in tandem, typically from 10 – 30 times, forming series with lengths of up to 
100 nucleotides (Jobling et al. 2014; Kouniaki et al. 2015). 
Microsatellites are more mutable than other parts of the human genome- 10-3 to 
10-4 versus 10-9 mutations per locus per generation (Jobling et al. 2014; Kouniaki et al. 
2015). Differences in mutation rates may however, differ according to several factors 
like: repeat number, repeat sequence, repeat configuration, and flanking sequence, in 
addition to the gender of the transmitting progenitor (Bhargava & Fuentes 2010). 
Several mechanisms have been suggested to explain this high mutation rate (Fan & 
Chu 2007; Bhargava & Fuentes 2010); however, it is commonly accepted that 
microsatellite mutations occur as a result of DNA replication slippage (Figure 1), even 
though direct evidence of the mechanism remains elusive (Jobling et al. 2014). 
STRs appear distributed throughout the human genome, accounting for about 3% 
of the entire genome, with one STR per 2,000 bp (Fan & Chu 2007; Eckert & Hile 
2009). Their distribution within chromosomes is not uniform and recent evidence 
pointed to their non-random genomic distribution (Eckert & Hile 2009), with most STRs 
found in noncoding regions (compared to only 8% located within exons) (Kouniaki et al. 
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Figure 1: Model of the effects of slippage and misalignment in microsatellite mutation (adapted from Jobling et al. 2014). 
 
2015). The length of common – mono-, di- and tetranucleotide – microsatellite alleles is 
dependent upon genome location. Generally, alleles within noncoding regions are 
longer than those within exons (Eckert & Hile 2009). In coding regions, STRs tend to 
occur in genes with roles in transcriptional regulation, DNA binding, protein-protein 
binding, and developmental processes. In these regions, STR mutations are generally 
in-frame additions or subtractions of repeat units, probably due to selective pressures. 
At some loci, STRs can expand above a given threshold, therefore leading to several 
neurological diseases as a consequence of dramatically expanded/deleterious alleles 
(Press et al. 2014). Many of these disease-associated STR expansions behave as 
dominant gain-of function mutations (Fan & Chu 2007; Press et al. 2014). 
 
2.2 Single Nucleotide Polymorphisms (SNPs) 
SNPs are nucleotide sites in a DNA sequence where more than one allelic state 
exist in some populations; usually, they are binary and the minor allele frequency is 1% 
or greater (Brookes 1999). SNPs are found in the human genome about once in every 
1,000 bp. Given that the human genome is 3,2 billion bp long, it can be estimated that 
there will be approximately 1 million differences between two human genomes, only 
due to SNPs (Goodwin et al. 2011). Among the principal genetic factors responsible for 
human phenotype variations are the SNPs, which account for approximately 90% of 
genetic variation observed in the human genome, with approximately 324 million SNPs 
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Figure 2: The CpG dinucleotide is a site for methylation (adapted from Jobling et al. 2014). 
identified (dbSNP-announce at ncbi.nlm.nih.gov, Thu Apr 6 2017) (Brookes 1999; 
Brumfield et al. 2003). 
Due to their low mutation rate (typically 10-8 mutations per nucleotide per 
generation), the chance of finding a SNP resulted from independent mutations in two 
individuals is small, reason why they tend to show identity-by-descent. Two 
fundamental processes lead to base substitutions: (a) misincorporation of nucleotides 
during replication; and (b) mutagenesis caused by the chemical modification of bases 
or physical damage. However, in both cases, sophisticated DNA repair processes can 
detect and repair a great part of base substitutions, resulting in germline mutations not 
transmitted to the next generation, which justifies the low SNP mutation rate (Jobling et 
al. 2014). 
Mutations on the origin of SNPs are abundant and widespread in the genome 
(coding and non-coding regions), with an important subset occurring in genes 
associated with diseases or other phenotypes (Morin et al. 2004; Grover & Sharma 
2014); nevertheless, as observed for STRs, the probability to find a SNP is higher in 
non-coding regions (Pinheiro 2010). In particular, in CpG dinucleotides, mutation rate is 
elevated because of methylation process. About 75% of CpG dinucleotides in our 
genome are targets of DNA methylation, a specific methyltransferase enzyme that 
adds a methyl group to the cytosine ring giving 5-methylcytosine (Figure 2). 
Spontaneous or mutagen-induced deamination (loss of an amine group) of cytosine 
yields uracil is not a legitimate base in DNA, being efficiently recognized and removed 
by uracil glycosidase. Deamination of 5-methylcytosine yields thymine, a legitimate 
DNA base. To fix this T-G mispair, either the T can be changed to a C, or the G to an 
A. Taking to account that repair machinery often makes the incorrect choice, CpG 
dinucleotides are hotspots for mutation (Jobling et al. 2014). 
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The biallelic state of the vast majority of these polymorphisms intrinsically limits 
the information that can be obtained from the analysis of any given SNP, which has 
been the major limiting factor for their application in forensic analysis: between 50 and 
80 SNPs are required to achieve the same levels of discrimination as the current STR 
based methods (Goodwin et al. 2011); however, when DNA samples are of low quality, 
the analysis of SNPs may be more effective (Pinheiro 2010). 
In the forensic field, SNPs have been attributed a continuously increasing 
importance since: a) their very low mutation rate is relevant for paternity testing; b) they 
are very suitable for analysis using high technologies, important for comprehensive 
databases; and c) they can be analysed in short amplicons, usually more desirable for 
the successful amplification of degraded samples (Sobrino et al. 2005). 
 
3. Triplet Repeat Diseases 
A new type of human genetic disease mutation was discovered more than twenty 
years ago – the expansion of repeated microsatellite sequences (La Spada & Taylor 
2010). In humans, consequences of triplet instability on health may be severe since the 
expansion of trinucleotide repeats is recognized as a major cause of several 
neurological and neuromuscular diseases (Budworth & McMurray 2013). The 
understanding of the pathogenic mechanism for this diseases is unknown, but has 
advanced substantially in recent years (McMurray 2010; Zhao 2015). Growing 
evidence supports the idea that repeat expansion diseases may be the result of 
aberrant DNA repair (Zhao 2015). 
The consequences of the expansion depend on some combination, including the 
location of the repeat within the affected gene, the size of the repeat unit, the number 
of repeats present in the deleterious allele and the sequence of the repeat (Zhao 
2015). Often, repeats in intronic regions are close enough to exons to disrupt genes 
functions, however disease-associated trinucleotides repeats are usually inside exons 
(Fan & Chu 2007). Among recurrent sequence motifs are (CAG)n, (CTG)n, and (GCG)n 
motifs, coding for polyglutamine, polyleucine and polyalanine tracts, respectively 
(Guyenet & La Spada 2006). The largest group of triplet repeat diseases is caused by 
polyglutamine tracts, most of them responsible for spinocerebellar ataxias (Budworth & 
McMurray 2013). 
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3.1 Spinocerebellar Ataxias 
Ataxias are a group of neurological disorders that result from variable levels of 
degeneration of neurons in the cerebellum, brain stem, spinocerebellar tracts, and their 
afferent/efferent connections. There are several different forms of inherited ataxias that 
strike during childhood or adulthood (Orr 2012). 
Spinocerebellar ataxias (SCAs), usually denoting autosomal dominant inherited 
ataxias, are a heterogeneous group of neurologic disorders characterized by variable 
degrees of degeneration in the cerebellum, spinal tracts and brain stem (Zoghbi & Orr 
2000). SCAs are considered rare disorders, with prevalence varying usually from 0.3 to 
2.0 per 100,000 individuals (Bettencourt & Lima 2011). There are approximately 40 
different types of SCAs described to date but not all causative mutations have been 
identified (Bird 1998; Orr 2012). Until now, more than twenty-seven genetic loci have 
been identify for SCA, namely the SCA1-8, SCA10-23, SCA25-30 and dentatorubral-
pallidoluysian atrophy (DRPLA) (Gomes et al. 2017). According to molecular 
mechanisms of disease, SCAs may be organized in four groups (Shakkottai & Fogel 
2013): 
1. Polyglutamine (polyQ) ataxias; 
2. Non coding repeats/ RNA toxicity; 
3. Ataxias associated with ion-channel dysfunction; and 
4. Ataxias associated with mutations in signal transduction molecules. 
At the genetic level, the most common polyQ ataxias are caused by an abnormal 
expansion of a CAG repeat sequence that encodes an expanded tract of polyQ 
residues within the mutated protein (Orr 2012). 
PolyQ disease proteins differ in size, cellular localization and biological function, 
suggesting that the toxic effect of a given polyQ expansion depends on the specific 
protein context, with particular details of pathogenesis probably unique to each disease 
(Costa & Paulson 2012). Potential mechanisms by which an elongated polyQ protein 
causes neuronal toxicity and further ataxia include: (a) protein misfolding resulting in 
altered function; (b) formation of toxic oligomeric complexes; (c) transcriptional 
dysregulation; (d) mitochondrial dysfunction; (e) impaired axonal transport; (f) aberrant 
neuronal signalling including excitotoxicity; (g) cellular protein homeostasis impairment 
and (h) RNA toxicity. These hypotheses are by no means mutually exclusive (Williams 
& Paulson 2008). 
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Figure 3: Distribution of neuronal loss. Red marks indicate regions with more prominent degeneration in MJD patient’s brains 
according to neuropathological studies (adapted from Saute & Jardim 2015). 
4. Machado-Joseph disease / spinocerebellar ataxia type 3 
Numerous designations have been given to this disorder, namely “Machado 
disease”, “nigro-spinodentatal degeneration with nuclear ophthalmoplegia”, “autosomal 
dominant striatonigral degeneration” and “Azorean disease of the nervous system” 
(Bettencourt & Lima 2011; Costa & Paulson 2012). At present, the most used 
designation is Machado-Joseph disease (MJD) or, alternatively, spinocerebellar ataxia 
type 3 (SCA3). 
 
4.1 Clinical Presentation 
MJD is a multisystem neurodegenerative disorder with autosomal dominant 
inheritance, described by a high degree of pleomorphism in the variability of age at 
onset and in the neurological signs, that result in different degrees of incapacity 
(Bettencourt & Lima 2011). 
Clinically, MJD is characterized by gait ataxia, spasticity, dystonia (repetitive 
muscle contractions), parkinsonism (subtype 4), myokymia (involuntary movements of 
facial and lingual muscles), dysarthria (motor speech disorder), dysphagia (swallowing 
problems), ophthamoparesis (abnormal eye movements), and diplopia (double vision) 
(Schöls et al. 2004; Costa & Paulson 2012; D'Abreu & Friedman 2016). 
Many pathology reports have been published. Macroscopic brain examinations 
showed the pallor of the substantia nigra as well as the degeneration of the cerebellum 
and brainstem (Figure 3) (Park et al. 2015). 
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The observation of three families of Azorean ancestry (Machado, Thomas and 
Joseph) led to the initial description, during the 1970s, of three apparently independent 
diseases. The first descriptions of MJD in Portugal were by Coutinho and Andrade in 
1978, who studied 15 families from the Azores (Coutinho & Andrade 1978). The 
subsequent identification of several Portuguese families, living in the Azores islands 
and in mainland Portugal, led to the unification of the disease as a single genetic entity 
with variable phenotypic expression (Bettencourt & Lima 2011). Initially, in 1978, 
Coutinho and Andrade systematized the disease phenotypes into three clinical types 
(Coutinho & Andrade 1978). Later, two more clinical types have been proposed as 
described in Table 1. 
 
Table 1: Clinical subtypes in MJD/SCA3 (Adapted from Bettencourt & Lima 2010; Saute & Jardim 2015). 
MJD subtype Clinical characteristics 
Type 1 - Joseph Early onset (progress more quickly), gait ataxia, pyramidal signs and dystonia. 
Type 2 - Thomas 
Most common type, intermediated onset, gait ataxia and with or without pyramidal 
sings. 
Type 3 - Machado 
Later onset, gait ataxia, associated with peripheral alterations, with or without slight 
pyramidal and extrapyramidal signs. 
Type 4 
Rare presentation with parkinsonian features, with mild cerebellar deficits and distal 
motor sensory neuropathy. 
Type 5 
Spastic paraplegia without gait ataxia (this designation has not been commonly 
accepted). 
 
4.2 Genetic Epidemiology 
MJD is the most common form of SCA worldwide (Teive et al. 2016). Among 
SCAs, the relative frequency of MJD is higher in countries such as Brazil- Rio Grande 
do Sul (92%) (Jardim et al. 2001), Portugal (58%) (Vale et al. 2010), Singapore (53%) 
(Zhao et al. 2002), China (49%) (Jiang et al. 2005), the Netherlands (44%) (Van de 
Warrenburg et al. 2002), Germany (42%) (Schöls et al. 1997), Japan (63%) (Shibata-
Hamaguchi et al. 2009), and it is considered as relatively rare in Canada (24%) (Kraft 
et al. 2005), México and Australia (12%) (Storey et al. 2000; Alonso et al. 2007), India 
(14%) (Krishna et al. 2007), South Africa (4%) (Bryer et al. 2003) and Italy (1%) 
(Brusco et al. 2004). Even within each country, the geographic distribution pattern is 
not homogeneous. In Portugal, for example, MJD is relatively rare in mainland 
(1/100,000), but highly prevalent in the Azores islands (1/239) (Bettencourt & Lima 
2011). 
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Two large studies have focused on the worldwide origin of MJD mutations. In 
2001, Gaspar et al., by haplotype analyses of five microsatellite markers flanking the 
ATXN3 gene and three intragenic SNPs (A669TG/G669TG, C987GG/G987GG and 
TAA1118/TAC1118), found that two (ACA and GGC) MJD haplotypes, were present in 
94% of all MJD families studied (Gaspar et al. 2001). In Azorean families, ACA 
haplotype was observed in Flores, while GGC haplotype was found in families from 
São Miguel. Their results indicated that two distinct mutational events accounted for the 
presence of MJD in the Azorean islands and in families of Azorean ancestry. In 
mainland Portugal, both haplotypes were also found. Worldwide, 72% of the families 
share the ACA haplotype, further supporting the idea of few mutational events 
responsible for MJD (Gaspar et al. 2001; Bettencourt & Lima 2011). Six years later, 
Martins et al. through a more extensive haplotype analyses (Martins et al. 2007), 
proposed an Asian origin for the worldwide spread MJD lineage. Their work revealed 
that TTACAC haplotype (or Joseph lineage) reached the highest diversity in Asia, with 
an estimated mutation age of ~ 7,000 years. A second de novo expansion, on 
Machado lineage (GTGGCA haplotype), is thought to be more recent (2,000 years old). 
The origin of Machado lineage is more controversial, but its dispersion may be mainly 
explained by recent Portuguese emigration (Martins et al. 2007; Bettencourt & Lima 
2011). 
 
4.3 ATXN3 gene 
In 1993, the disease locus for MJD was mapped to the long arm of chromosome 
14, by Takiyama et al. (Takiyama et al. 1993). One year later, Kawaguchi et al. showed 
that an expansion of a CAG repeat motif at the MJD1 gene (currently named ATXN3), 
mapped to 14q32.1, was present in all individuals with MJD disease (Kawaguchi et al. 
1994). The genomic structure of this gene was published seven years later (Figure 4) 
(Ichikawa et al. 2001). In MJD, the CAG repeat is located in the penultimate exon of the 
canonical ATXN3 transcript. The expanded repeat encodes an almost pure 
polyglutamine stretch interrupted by a single lysine codon due to CAG/CAA codon 
degeneracy (CAG)2CAA AAG CAG CAA(CAG)n (Kawaguchi et al. 1994). Wild-type 
alleles range from 11 to 44 CAG repeats, whereas limits of expanded alleles usually 
comprise from 61 to 87 repeats units (Martins et al. 2012). Intermediate size alleles are 
rare. To date, only seven alleles have been reported, six of them associated to different 
clinical presentations of MJD [45 (Padiath et al. 2005), 51 (Gu et al. 2004), 53 (Van 
Alfen et al. 2001), 54 (Van Alfen et al. 2001), 55 (Egan et al. 2000), 56 (Takiyama et al. 
1997)], and the seventh allele, with 51 repeats, has been described as being 
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apparently not associated with disease. This raised the possibility that low penetrance 
alleles, of intermediate size, may occur in MJD (Maciel et al. 2001; Bettencourt & Lima 
2011). Recently, Takahashi et al. described a family with compound heterozygous 
individuals presenting intermediate ATXN3 alleles (55/49) associated with progressive 
cerebellar ataxia and sensory axonal neuropathy. Their results suggested that two 
intermediate alleles carried by the same individual potentiates the phenotypic 
expression of the disease, suggesting multiple mechanisms for the development of 
MJD (Takahashi et al. 2017). 
ATXN3 gene encodes the ataxin-3 protein (~42 kDa), which belongs to the family 
of cysteine proteases, described as being involved in protein quality control pathways 
in the cell, transcriptional regulation and cytoskeleton organization (Bettencourt & Lima 
2011; Matos et al. 2016). Different studies demonstrated that ataxin-3 is ubiquitously 
transcribed in neuronal and non-neuronal human tissues. Regarding its subcellular 
location, ataxin-3 has been observed both in the cytoplasm and the nucleus of various 
cell types. Thus, cellular expression of this gene is not itself sufficient to explain 
selective neuronal degeneration (Bettencourt & Lima 2011). 
Recently, fifty-six alternative splicing variants generated by four types of splicing 
events (which can occur in combined way) were described for the ATXN3 gene 
(Bettencourt & Lima 2011; Matos et al. 2011). Thus, alternative splicing may be an 
important mechanism regulating ataxin-3 diversity. In its mutated form, when the polyQ 
tract reaches the pathological threshold, the protein is thought to gain a neurotoxic 
function with protein aggregations formed inside the cell that, as a consequence, lead 
to selective neuronal cell death through a not fully understood process (Bettencourt & 
Lima 2011). 
 
 
 
 
 
Figure 4: Schematic representation of the ATXN3 gene structure. Exons are numbered from 1 to 11, represented as boxes. Blue boxes 
indicate the coding regions. The location of the polymorphic (CAG)n tract is indicated (adapted from Bettencourt & Lima 2011). 
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4.4 Genotype-phenotype correlation 
Machado-Joseph disease shows an autosomal dominant pattern. Thus, each 
descendent of an affected individual has, a priori, a risk of 50% of being itself a carrier, 
with both genders having equal probabilities of receiving/transmitting the expanded 
allele and expressing the disease (Bettencourt & Lima 2011). 
The allele size (CAG repeat length) is the major determinant of disease age-of-
onset, progression and severity phenotype (Martins et al. 2014). An inverse correlation 
is found between the size of the expanded CAG repeat tract and the age-of-onset (AO) 
of the disease (Bettencourt & Lima 2011). 
The expanded repeats are unstable, especially in male meiosis, with tendency to 
expand. This leads to earlier onsets and more severe phenotypes in following 
generations – a clinical phenomenon known as anticipation (Schöls et al. 2004). Such 
phenomenon can be explained by the dynamic process of mutation underlying triplet 
repeats diseases, which involves intergenerational instability (Bettencourt & Lima 
2011). Most cases of childhood onset are caused by extreme expansions between 
generations (Schöls et al. 2004). CAG repeat instability can also occur in different cells 
from the same tissue, originating somatic mosaicism. In MJD, somatic mosaicism may 
occur in the brain, but larger repeats are not preferentially associated with affected 
brain regions (Costa & Paulson 2012). 
The genetic background is another factor that seems to influence instability of 
repeats (Martins et al. 2008).The presence of several SNPs an STRs flanking the CAG 
tract have permitted a better understanding of the mechanisms behind repeat instability 
(Costa & Paulson 2012). Previously studies demonstrate that, in MJD some 
polymorphisms have an inter-allelic interaction on the allele from the normal 
chromosome that influence the intergenerational instability of expanded alleles. This 
was a strong evidence that elements in trans may affect repeat instability (Martins et al. 
2008). Also, in 2015, two novel SNPs (rs709930 and rs910369) were analysed in 
Chinese patients, possibly genetic modifiers in MJD since they have been associated 
to a decrease of approximately 2 to 4 years in MJD AO (Long et al. 2015). 
Cases of homozygosity are extremely rare in MJD, but the few described 
homozygous patients for the expansion appear to show a more severe form of disease 
suggesting a gene dosage effect (Carvalho et al. 2008; Costa & Paulson 2012); with a 
more severe progression and an early AO (Carvalho et al. 2008; Zeng et al. 2015). 
Loss of function of the normal expressed ataxin-3, or possibly aggregation of ataxin-3, 
may be implicated in disease mechanism (Carvalho et al. 2008). 
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Additionally, evidence of the contribution of genetic and/or environmental factors 
to disease presentation came in 2011, when it was proposed that epigenetic factors, 
such as DNA methylation in the promoter region of the ATXN3 gene might contribute to 
clinical variation, with a small and positive effect on the AO (Emmel et al. 2011). More 
recently, Wang et al. found higher methylation levels in the first CpG island of the 
ATXN3 promoter in MJD patients with earlier AO and unstable intergenerational 
transmissions of the CAG repeats (Wang et al. 2017). 
 
4.5 Pathology 
Alternative splicing may play an important role in MJD, as mentioned earlier. By 
analysing the domain composition of several ataxin-3 isoforms, it has been possible to 
predict a protective role for some isoforms, while others showed to lead to increased 
toxicity (Bettencourt et al. 2010). Independently of ataxin-3 isoform, it has been 
observed that ataxin-3 subcellular distribution differs in diseased brain compared to 
normal brain. Thus, cytoplasmic proteins are normally observed in normal brain, 
whereas during disease, ataxin-3 becomes concentrated in the nucleus of neurons with 
formations of intranuclear inclusions in many brain regions (Paulson et al. 1997). These 
neuronal inclusions, pathological hallmark of MJD, are severely ubiquitinated and 
contain certain heat shock molecular chaperones and proteasomal subunits, 
suggesting that they are repositories for aberrantly folded, aggregated proteins (Chai 
2002; Schmidt et al. 2002). Functional interactions of wild-type ataxin-3 with other 
molecules have been shown to reduce its aggregation propensity and increase 
solubility. In the case of mutant ataxin-3, it is possible that these modifier interactions 
are reduced, leading to a faster rate of aggregation. Expanded ataxin-3 interacts 
abnormally with at least some of its native partners, impeding its own degradation and 
leading, in some cases, to a gain-of-function and, sometimes to partial loss of normal 
ataxin-3 function (Costa & Paulson 2012). 
Numerous hypotheses, not mutually exclusive, have been considered while 
studying the potential toxic mechanism caused by misfolded mutant ATXN3 and its 
altered proteins interaction: (i) formation of aggregates; (ii) failure of cellular protein 
homeostasis; (iii) impairment of axonal transport; (iv) transcriptional dysregulation; (v) 
mitochondrial dysfunction and oxidative stress; and (vi) abnormal neuronal signalling 
(Costa & Paulson 2012). 
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Objectives 
Given the importance of haplotype analyses in the context of repeat-expansion 
disorders, our main objective for this study was to extend these analyses through the 
genotyping of a battery of polymorphic markers flanking our repeat of interest - ATXN3-
(CAG)n. Therefore, we aimed at designing a pipeline to perform a comprehensive 
haplotype analyses in MJD that will be useful to complete studies on tracing spreading 
routes of MJD mutations. 
Our specific goals were: 
1. To design a protocol to access allelic phases of expanded MJD alleles and 
flanking SNPs; 
2. To identify the best panel of SNPs to distinguish the two main MJD 
lineages identified so far: Machado and Joseph; 
3. To identify the most informative SNPs to distinguish normal and expanded 
alleles in MJD patients from different lineages, further useful for allele-specific down 
regulation of expanded alleles during siRNA therapies; 
4. To identify de novo mutational origins in Machado-Joseph disease. 
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Subjects and Methods 
1. Subjects 
We studied forty-three families with MJD, twenty-one from Portugal and twenty-
two from Taiwan. The Portuguese samples are from Centro de Genética Preditiva e 
Preventiva (CGPP) – i3S/IBMC, where the molecular diagnosis of MJD is performed; 
written informed consent has been previously provided by all individuals. Taiwan 
samples have been sent by Dr. Bing-Wen Soong from Neurological Institute, Veterans 
General Hospital, Taipei, Taiwan. The length of normal and expanded polyglutamine 
tracts was previously determined by capillary electrophoresis. DNA quantification was 
performed with Nanodrop spectrophotometer to make work aliquots with a final DNA 
concentration of approximately 7.5 ng/µL. 
 
2. Primer design 
To amplify and sequence a 4 kb region flanking exon 10 of the ATXN3 gene, we 
designed sequence specific primers (Sigma) (Table 2) by using the online software 
Primer3Plus (Rozen & Skaletsky 1999), with the following conditions: 18 to 27 bp; a 
melting temperature comprised between 57°C and 63°C; a percentage of GC between 
20% and 80%; in the mispriming/repeat library of the human species. Next, to test the 
occurrence of hairpins and primer self-dimers, we used the OligoCalc algorithm (Kibbe 
2007): sequences prone to form hairpin structures were discarded. The alignment tool 
BLAT (Kent 2002) (human genome, assembly GRCh38/hg38) was then used to 
guarantee the specificity of designed primers to the target sequence, and finally, each 
primer was subjected to a nucleotide BLAST (Johnson et al. 2008) (database: 
nucleotide collection; organism: human; expected threshold: 10; megablast) to find 
similar sequences. The compatibility of multiple primer sequences was checked with 
AutoDimer software (Vallone & Butler 2004), which detects the formation of primer-
dimers in short DNA oligomers. 
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Table 2: Primers designed to amplify and sequence a 4 kb region flanking the ATXN3-(CAG)n repeat. F - Forward primer; R – 
Reverse primer. 
 
3. PCR Optimization 
After optimization of PCRs with the primers described above, five singleplex were 
performed (Table 3) in order to amplify the 4 kb sequence of ATXN3 (Figure 5). We 
performed two types of PCR: one including the CAG repeat, which resulted in the 
overrepresentation of normal over expanded alleles; and others not encompassing the 
repetitive CAG, which resulted in the equal amplification of both paternal and maternal 
inherited alleles. This way, we were able to determine the allelic phase of analysed 
SNPs and infer haplotypes segregating with the MJD expansion. All amplification 
reactions had a final volume of 10 µL, with the reagents described in Table 4, and PCR 
conditions in Table 3 and Table 5. 
 
  
Name Primer sequence (5’-3’) 
Clo F * F CAATTATTGGCCTTTCTGAACC 
MJDClo 653* R GCAAATGAGTGTTGGTTTATAGACCC 
MJDClo 716* F ACAGAGTCTCGCTCTGTCGCCCAG 
MJDClo 52 * F CCAGTGACTACTTTGATTCG 
MJDClo 1260 * R GCTGTCTGAAACATTCAAAAGTGAAG 
MJDClo 1342* F CCACCAGTTCAGGAGCACTT 
MJDClo 7a * R TGCTCCTTAATCCAGGGAAATTTAG 
MJDClo 1396 F TCATGTTCGCTACCTTCACACT 
MJDClo 2109* F GAGTTACTTTCCAGGTCTCGG 
MJDClo 2129* R CCGAGACCTGGAAAGTAACTC 
MJDClo 2552 * F GATCCAGCAGTCCCAATCATGTA 
MJDClo 2646 R TGCCTGGTCAGCTATAAGCA 
MJDClo 2942* F TGGACACGGTGGCTTACGCCT 
MJDClo 3695 R GAGTTTTGCTCTTGTTGCCCAG 
Clo R * R AGCCTTCTCTAACACCACCTTGG 
*Primers designed in previous studies. 
Figure 5: Schematic representation of the 4 kb ATXN3 sequence and primers used to amplify the whole region. 
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Table 3: Haplotypic and genotypic PCRs, with temperatures of annealing (a) and times of extension (b). 
Haplotypic PCR 
Length 
(bp) 
a b Genotypic PCR 
Length 
(bp) 
a b 
CloF-MJDClo7a 1537 60 ̊C 2 min CloF-MJDClo1260 1260 62°C 1 min 30 s 
MJDClo52-MJDClo7a 399 62 ̊C 1 min 
MJDClo1342-
MJDClo2646 
1305 59 ̊C 2 min 
    MJDClo2552-CloR 1542 61 ̊C 2 min 
 
Table 4: PCR reagents. 
Reagents Volume (µL) 
5x Q solution (QiaGen®) 1 
Primer forward (2.5 µM) 0.5 
Primer reverse (2.5 µM) 0.5 
Water (ddH2O) 1 
DNA sample (7.5 ng/µL) 2 
Taq polymerase (QiaGen Master Mix; QiaGen®) 5 
Total 10 
 
Table 5: PCR protocol for the amplification of different fragments within the ATXN3 4 kb region under analysis. a and b are the 
temperature of annealing and time of extension, respectively, indicated in Table 3. All PCRs had 35 cycles, except CloF-
MJDClo1260 (33 cycles). 
Initial denaturation Denaturation Annealing Extension Final extension 
95 ̊C 94 ̊C a 72 ̊C 72 ̊C 
15 min 40 s 1 min 30 s b 10 min 
     35 cycles  
 
4. Detection of amplified products 
In order to visualize the presence and the length of amplified DNA fragments, 
PCR products were subjected to electrophoresis in a polyacrylamide gel and coloration 
has been done with silver staining. Two glass supports previously cleaned and treated 
with blueslick (Serva), separated by a hydrophilic gel film (Gel-FixTM, Serva), were used 
to produce a thin gel composed by an acrylamide-bisacrylamide solution, ammonium 
persulfate and TEMED (Table 6). 
 
Table 6: Reagents used in the polyacrylamide gel. 
Reagents Volume Function 
40% (w/v) Acrylamide:bisacrylamide (19:1) solution (AccuGel 19:1 ; 
National Diagnostics) 
3 mL Gel 
Ammonium persulfate 2.5% (Promega) 170 µL Oxidizing agent 
TEMED (Amersco®) 7 µL Catalysis agent 
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After gel polymerization was complete at room temperature, we placed the gel on 
an electrophoretic system (Multiphor II, GE Healthcare), previously refrigerated by a 
thermostatic circulator at 4ºC (MultiTemp III, Amersham Biosciences). We used 1.2 µL 
of each PCR product to load the wells. In order to infer the length of obtained 
fragments, we also loaded one well with a molecular marker (100 bp Plus; Thermo 
Scientific). 
We used paper strips, soaked in buffer, which were placed at both anode (+) and 
cathode (-), to allow the horizontal run. The addition of bromophenol blue dye (Merck) 
to the cathode allowed the visualization and control of the electrophoresis. 
The electrophoresis run initially at 180 V; after samples started to migrate, we 
increased the voltage to 220 V. The electrophoresis power supply (Consort EV243) 
was turned off when the marked dye approached the anode strip. 
The coloration method involved six steps, neatly described in Table 7, all of them 
at room temperature and under agitation (Burgwedel). 
 
Table 7: Steps of coloration with silver staining. 
Step Time Compounds 
(1) Fixation of the DNA 
10 min 10% ethanol 
5 min 1% nitric acid (Merck) 
(2) Washing 10 min, twice Deionized water 
(3) Coloration 
20 min (protected from 
the light) 
0.2% silver nitrate solution (Merck) 
(4) Washing 10 s, twice Deionized water 
(5) Revelation of DNA 
fragments 
Until bands start to 
appear 
0.28 M sodium carbonate anhydrous (Applchem) 
and 0.02% formaldehyde (Merck) 
(6) Stop the revelation ~10 s 10% acetic acid (Merck) 
 
Ended the process, we left the gel in water, for at least 12 hours, and then dried 
at room temperature (RT). 
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5. DNA sequencing 
After analysing the obtained fragments and confirming PCR specificity, DNA 
sequencing was performed in each PCR product with the respective sequencing 
primers. This method included two purifications and a PCR sequencing reaction. An 
initial purification, using an exonuclease and an enzyme thermosensitive alkaline 
phosphatase, was done in order to degrade unreacted primers and remained dNTPs 
(Table 8 and 9). 
Depending on the PCR performed, sequencing primers were chosen as indicated 
in Table 10. Together with the purified product (2.8 µL), a sequencing mix (Table 11) 
was subjected to a sequencing reaction with the conditions described in Table 12. 
 
Table 8: Reagents and quantities for PCR purification. 
Compounds Volume (µL) 
PCR product 1.85 
ExoI: FastAP (1:5) (Thermo Scientific) 0.95 
Total 2.80 
 
Table 9: Protocol for PCR purification 
(1) To activate the enzyme (2) To inactivate the enzyme 
37°C 80°C 
15 min 15 min 
 
Table 10: Primers used to perform sequencing reaction. 
PCR amplified Sequencing primers 
CloF-MJDClo1260 
MJDClo653 R 
MJDClo716 F 
CloF-MJDClo7a 
MJDClo653 R 
MJDClo716 F 
MJDClo7a R 
MJD52Clo-MJDClo7a MJDClo7a R 
MJDClo1342-MJDClo2646 
MJDClo1396 F 
MJDClo2109 F 
MJDClo2129 R 
MJDClo2552-CloR 
MJDClo2942 F 
CloR R 
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Table 11: Reagents and volumes for sequencing mix 
Compounds Volume (µL) 
Primer (2.5 µM) 0.5 
Sequencing buffer (2.5x) (Applied Biosystems) 0.75 
ABI Prims® BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) 0.5 
Water (ddH2O) 0.75 
Total 2.50 
 
Table 12: Sequencing reaction conditions. 
Initial denaturation Denaturation Annealing Extension Final extension 
96̊C 96 ̊C 58ºC 60 ̊C 60̊C 
2 min 15 s 5 min 2 min 10 min 
      30 cycles  
 
We did an ultimate purification to isolate the sequencing products, by using a 
cross-linked dextran matrix in order to separate molecules over broad molecular 
weight. The centrifugation (Mikro 200, Hettich Zentrifugem) of illustraTM SephadexTM G-
50 (GE Healthcare) for 4 minutes at 4400 rpm allowed the formation of columns. After 
loading the PCR sequencing product in the center of the column, the same conditions 
of centrifugation resulted in a deposit containing the final product. 
To guarantee the stability of single-stranded DNA, we added 12 µL of Hi-DiTM 
formamide (Applied Biosystems) to the final product. This stability is necessary for 
capillary electrophoresis in an ABI PRISM 2130x/Genetic Analyzer (Applied 
Biosystems). 
 
6. In silico analyses 
All obtained sequences were aligned with Geneious 5.5.8 software (Kearse et al. 
2012), which allowed global alignments and comparison with the reference sequence 
to detect sequences variants. 
PHASE 2.2 software (www.stat.washington.edu/stephens/software.html) was 
used to reconstruct haplotypes from genotypic data when the allelic phase of SNPs 
and expanded MJD alleles could not be directly inferred by family segregation or by 
allele-specific amplification. Allele frequencies and phase-known haplotypes were 
taken into account, but only haplotype pairs with a probability greater than 0.6 were 
used for further analyses. 
Phylogenetic networks were performed using the Network 5.0.0.1 software 
(www.fluxus-engineering.com) to gain insight into the ancestral haplotypes and 
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evolutionary branching trees. Since we used microsatellite data, a combined reduced 
median and median-joining calculation was performed with the objective to reduce 
reticulation and simplify the network. To draw the phylogenetic networks we used 
seven STRs (TAT223, GT199, ATA194, AC21, AAAC123, GT190 and AC190) and the SNP 
rs56268847; the weights for each STR was calculated from the molecular diversity data 
calculated by Arlequin 3.5.2.2 software (Excoffier & Lischer 2010); also we attributed 
the maximum weight (10) for the only analysed SNP; in networks, circle area is 
proportional to frequency, branch length is proportional to the number of mutations and 
diamonds indicate recombination. 
To assess more accurately the molecular distance among the different STR 
haplotypes of each lineage, a pairwise analysis of the flanking haplotypes was also 
performed with Arlequin, applying the sum of squared size difference (Rst) as the 
distance method. This way, the estimation of evolutionary distance between each pair 
of haplotypes was calculated taking into account the number of presumed single-step 
mutation steps between the corresponding STR alleles. 
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Results 
During the optimization process, we tried to amplify our region of interest by using 
several enzymes – MyTaqTM Mix (Bioline); QiaGen Multiplex PCR Kit (QiaGen®); 
Advantage® Genomic LA Polymerase Mix (Clontech Laboratories, Inc.); DFS–Taq 
DNA Polymerase (BioRon); Ranger DNA Polymerase (Bioline); LongPCR Enzyme Mix 
(Thermo Scientific); and Advantage® GC Genomic LA Polymerase Mix (Clontech 
Laboratories, Inc.). Multiple amplification conditions have been applied, but we 
succeeded to amplify regularly and evenly both Portuguese and Taiwan DNA samples, 
when amplifying samples with the QiaGen enzyme. 
Protocols optimized to cover a 4 kb region encompassing the MJD repeat 
allowed us to, more easily, infer haplotypes segregating with the (CAG)n expansion of 
all families studied, in the both Portuguese and Taiwanese populations. However, 
some PCRs, performed in some samples did not amplify the target sequence; in these 
cases, we adopted three strategies, following the order described below: 
1. To decrease 2°C in the annealing temperature (Tm); 
2. To increase DNA concentration (15 ng/µL), and; 
3. To perform both procedures above, (1) and (2), at the same time. 
Depending on the PCR type (either encompassing or not the CAG expansion) 
and PCR specificity (preferential amplification of the normal allele over the expanded 
one), we obtained a different length of amplified DNA fragments in a polyacrylamide gel 
(Figure 6). 
 
 
Figure 6: Polyacrylamide gel image showing the amplified products resulted from different PCRs. (a) Unspecific PCR, by using 
MJD52 and MJD7a primers; (b) Specific PCR obtain with CloF and MJD7a primers, in which it is possible to distinguish both 
normal and expanded alleles; (c) Specific PCR obtained with MJD1342 and MJD 2646 primers; (d) PCR specific for the 
amplification with primers MJD2552F and CloR (non-specific PCR for sample N12-6384 (well 2) probably due to excess of DNA). 
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Before using the Geneious software to align our sequences with the reference 
sequence, we interpreted results taking into account the PCR from which sequences 
had been originated: either (CAG)n-biased PCR (with the normal allele more frequently 
represented over the expanded one) or regular PCR (with sequences from both 
homologous chromosomes equally amplified). When the PCR included the CAG repeat 
(CloF-MJD7a and MJD52-MJD7a), we first verified if both alleles (normal and 
expanded) were amplified (Figure 7, Figure 8 and Figure 9). If this was the case, we 
next identified the existence of slippage, as demonstrated in Figure 9, so that there was 
no misinterpretation of the downstream polymorphic positions. 
 
Figure 7: Electropherogram of a sequencing reaction encompassing the CAG repeat region in which only the expanded allele was 
amplified. 
 
Figure 8: Electropherogram of a sequencing reaction encompassing the CAG repeat region, where both normal and expanded MJD 
alleles have been amplified. 
 
Figure 9: Electropherogram of a sequencing reaction encompassing the CAG repeat region with both normal and expanded MJD 
alleles amplified and in which slippage of the normal allele is also detected. 
 
Therefore, we proceeded to the genotypic analysis of the polymorphic positions. 
When both (CAG)n alleles were amplified, we could face three situations for the SNP 
under study: i) the detection of a single base (Figure 10), with the allele segregating 
with the expansion directly inferred; ii) two equally represented peaks (Figure 11), 
which did not allow us to infer the allele in phase with MJD expansion; and, iii) two 
unbalanced peaks (Figure 12), with the lowest peak representing the SNP allele 
segregating with the expansion. 
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Figure 10: Sequence of a patient homozygous for the SNP rs7158733; amplification done with MJD-CloF and MJD7aR primers, 
and sequencing with MJD 7a primer. 
 
Figure 11: Sequence of a patient heterozygous for the SNP rs10467857; amplification done with MJD-CloF and MJD7aR primers, 
and sequencing with MJD 716 primer. 
 
Figure 12: Sequence of a patient heterozygous for the SNP rs56268847; amplification with MJD-CloF and MJD7aR primers, and 
sequenced with MJD 653 primer. 
 
In cases where the PCR did not encompass the repetitive MJD tract (CloF-
MJD1260, MJD1342-MJD2646 and MJD2552-CloR), interpretation of results was 
straightforward, with clear homozygous and heterozygous individuals for the analysed 
SNPs, with single peaks or equally amplified and detected peaks, respectively. 
Whenever allelic phases could not be inferred based on both (CAG)n-biased or 
regular PCRs, we genotyped other family members to obtain the complete MJD SNP-
based haplotype by family segregation. Our cohort of 43 families includes 65 MJD 
patients, of which 36 of Taiwanese and 29 of Portuguese origin. To complete haplotype 
inference by segregation, we also genotyped some non-affected relatives of different 
Taiwanese families. Genotypes for all studied individual are detailed in Supplementary 
material 1 and 2. For isolated cases or non-informative families, we resorted to the 
PHASE software to reconstruct haplotypes (Supplementary material 3 and 4). 
We analysed all variable sites comprised within our region of interest, however, 
we focus on 23 SNPs that showed to be polymorphic in, at least, one of our analysed 
populations. With the exception of rs56268847 (A/G.485) and rs111735934 
(G/A.3770), all analysed SNPs were polymorphic in both populations. As for 
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rs56268847 (A/G.485), all Portuguese individuals genotyped by us were homozygous 
for the A allele, in agreement with allele frequencies for the European control 
population (A/G: 1/0; Table 13). On the contrary, our results for SNP rs111735934 
(G/A.3770) have shown a fairly high heterozygosity in our Portuguese cohort (53%), 
whereas reported value for the control European population was 0.002 (Table 13). 
Among studied polymorphic positions, we highlighted 19 SNPs that distinguish the 
Machado and Joseph lineages (underlined in Table 14), and three SNPs, rs10467857 
(C/G.910), rs2006047 (A/G.3645) and rs7142326 (A/G.3912), that have shown a high 
polymorphic information content values (PICs of 67%, 68% and 89%, respectively; 
Table 13 and Table 14). 
Our cohort of Portuguese samples (21 MJD families) was chosen based on their 
STR diversity (8 different STR haplotypes, previously assessed by Martins et al., 2007 
and Inês Costa, personal communication) since our aim was to study families more 
likely to have different ancestors. As for the Taiwanese families, taking into account 
their high STR diversity (13 STR-haplotypes found in 22 families), we included all 22 
families in our SNP analysis. 
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Table 13: Heterozygosity of Portuguese and Taiwanese MJD patients for SNPs flanking the (CAG)n repeat at ATXN3. H|T: number of heterozygous patients by total number of analysed patients, with percentages for 
total (%T), Portuguese (%PT) and Taiwanese (%TW) MJD populations. European (EUR) and East Asian (EAS) control populations. 
SNP refSNP ID H|T %T %PT %TW 
Heterozygous genotype 
frequency(Yates et al. 2016) 
Allele frequency(Yates et al. 2016) 
      EUR EAS EUR EAS 
C/T.124 rs12586535 29|55 53 42 61 0.316 0.466 C: 78% T: 22% C: 56% T: 44% 
C/T.248 rs12586471 24|50 50 33 66 0.316 0.468 C: 22% T: 78% C: 44% T: 56% 
A/G.485 rs56268847 11|58 19 0 32 0 0.103 A: 100% G: 0% A: 95% G: 5% 
G/A.868 rs10467858 28|54 52 42 60 0.316 0.468 G: 78% A: 22% G: 56% A: 44% 
C/G.910 rs10467857 37|55 67 76 60 0.398 0.476 G: 34% C: 66% G: 53% C: 47% 
T/C.921 rs10467856 27|54 50 38 60 0.316 0.468 T: 78% C: 22% T: 56% C: 44% 
C987GG/G987GG rs12895357 30|55 55 46 56 0.414 0.470 G: 73% C: 27% G: 58% C: 42% 
TAA1118/TAC1118 rs7158733 30|56 54 44 61 0.316 0.468 C: 78% A: 22% C: 56% A: 44% 
C1178/A1178 rs3092822 28|57 49 42 55 0.316 0.468 A: 78% C: 22% A: 56% C: 44% 
G/A.1548 rs7158238 20|45 44 39 50 na* na* G: na* A: na* G: 47% A: 53% 
A/G.1694 rs12588287 26|52 50 42 58 0.316 0.466 A: 78% G: 22% A: 58% G: 42% 
G/A.1714 rs7153615 26|52 50 42 58 0.314 0.468 G: 78% A: 22% G: 56% A: 44% 
G/A.1737 rs7153603 26|52 50 42 58 0.314 0.468 G: 78% A: 22% G: 56% A: 44% 
C/T.1857 rs7153696 26|52 50 42 58 0.316 0.468 C: 78% T: 22% C: 56% T: 44% 
G/A.1886 rs7153374 26|52 50 42 58 0.316 0.468 G: 78% A: 22% G: 56% A: 44% 
G/T.1959 rs7153193 26|52 50 42 58 0.316 0.470 G: 78% T: 22% G: 56% T: 44% 
T/C.2992 rs4904833 13|25 52 43 56 0.316 0.468 T: 78% C: 22% T: 56% C: 44% 
C/T.3137 rs7146985 14|27 52 43 55 0.316 0.468 C: 78% T: 22% C: 56% T: 44% 
T/A.3209 rs113572439 14|31 45 27 55 0.316 0.468 T: 78% A: 22% T: 56% A: 44% 
A/G.3645 rs2006047 30|44 68 79 60 0.398 0.476 A: 66% G: 34% A: 47% G: 53% 
G/A.3738 rs8004149 21|43 49 39 56 0.316 0.468 G: 78% A: 22% G: 56% A: 44% 
G/A.3770 rs111735934 10|44 23 53 0 0.002 0 G: 99.9% A: 0.1% G: 100% A: 0% 
A/G.3912 rs7142326 25|38 89 19 58 0.398 0.476 A: 66% G: 34% A: 47% G: 53% 
*na - not available           
X – ancestral alleles are underlined          
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Table 14: SNP-based haplotypes of Portuguese and Taiwanese MJD families with the most frequently observed Joseph and Machado lineages. 
 
  
SNP refSNP ID Distance from the (CAG)n (bp) 
Location in 
ATXN3 
Machado 
lineage 
Joseph lineage 
Joseph-derived 
lineage: 
    PT PT TW A/G.485 
C/T.124 rs12586535 1249 Intron 10 C T T T 
C/T.248 rs12586471 1125 Intron 10 T C C C 
A/G.485 rs56268847 888 Intron 10 A A A G 
G/A.868 rs10467858 505 Intron 10 G A A A 
C/G.910 rs10467857 463 Intron 10 G G G G 
T/C.921 rs10467856 452 Intron 10 T C C C 
(CAG)exp   
C987GG/G987GG rs12895357 1 Exon 10 G C C C 
TAA1118/TAC1118 rs7158733 132 Exon 10 C A A A 
C1178/A1178 rs3092822 192 Exon 10 A C C C 
A/G.1548 rs7158238 250 Exon 10 G A A A 
A/G.1694 rs12588287 396 Intron 11 A G G G 
A/G.1714 rs7153615 416 Intron 11 G A A A 
A/G.1737 rs7153603 439 Intron 11 G A A A 
A/G.1857 rs7153696 559 Intron 11 C T T T 
G/A.1886 rs7153374 588 Intron 11 G A A A 
T/G.1959 rs7153193 661 Intron 11 G T T T 
T/C.2992 rs4904833 1694 Intron 11 T C C C 
C/T.3137 rs7146985 1839 Intron 11 C T T T 
T/A.3209 rs113572439 1911 Intron 11 T A A A 
A/G.3645 rs2006047 2347 Intron 11 G G G G 
G/A.3738 rs8004149 2440 Intron 11 G A A A 
G/A.3770 rs111735934 2472 Intron 11 A* G G G 
A/G.3912 rs7142326 2614 Intron 11 G G G G 
*(Martins et al. 2012)  
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Of the 21 Portuguese MJD families analysed, 62% belong to Machado lineage, 
and the remaining 38% are from the Joseph background. All Taiwanese families (n=22) 
analysed by us shared most SNP alleles with the commonly observed Joseph lineage. 
In this population, we observed allelic states of SNP rs56268847 (A/G.485) in phase 
with the expansion to differ among families. Eight MJD Taiwanese families shared the 
Joseph-derived haplotype, i.e., Joseph background with a G variant in the SNP 
A/G.485 (Table 15). 
 
Table 15: SNP-based lineages for the analysed MJD families. 
Machado families PT P52; P57; P63; P67; P72; P83; P97; P110; P111; P114; N13; N14; N15 
Joseph families 
PT P10; P91; P96; P99; P112; P117; N12; N19 
TW S2; S3; S7; S8; S9; S10; S13; S15; S19; S20; S21; S22; S23; S25 
Joseph-
derived 
A/G.485 TW S1; S4; S5; S6; S12; S17; S18; S24 
 
A phylogenetic network was performed with all studied Taiwanese families based 
on their previously assessed STR haplotype in order to find phylogenetic distances 
between Joseph and Joseph-derived families. We can notice four evolutionary 
branches evolving from a possibly common ancestor. A clear separation is noticed for 
Joseph and Joseph-derived lineages, with at least 6 mutation steps apart between 
them, at the following polymorphic markers: GT199, TAT223, AC190 and AC21 (H10-H12); 
Unexpectedly, the H7 haplotype seems to be closer to Joseph-derive families, even if 
this family shares all SNPs analysed by us with the most common Joseph lineage 
(patient 3.S9 is homozygous A/A for the SNP A/G.485; Figure 13; Supplementary 
material 5). However, if we compared the haplotypes H6 and H7 we can count 4 
mutations steps between them, while the H23 and H7 have 5 mutations steps. The 
reason why the software draw a network including the haplotypes H7 and H23 in the 
same branch, may be justified because of the maximum parsimonious principle on 
which it is based this software and because the weight that we gave at each marker 
analyse. In pairwise H6-H7 the mutation occur at GT190 marker which have higher 
weight (5) than the GT199 marker (4), where occur 4 of 5 step mutations that distinguish 
the haplotypes in pairwise H7-H23. 
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In order to increase the specificity of relationships among haplotypes we included 
the A/G.485 SNP marker in the analysis to draw a new phylogenetic network (Figure 
14). Thus, we obtained a new network with more step mutations (7) separating both 
Joseph and Joseph-derived haplotypes and with an older common ancestral haplotype; 
the H7 haplotype remained, however, closer to Joseph-derived than to Joseph 
backgrounds. 
 
 
 
 
 
 
 
Figure 14: Phylogenetic network showing the most parsimonious relationships among STR haplotypes and including also the SNP 
A/G.485. Different colours denote Taiwanese Joseph (green) and Joseph-derived (blue) families. 
 
Next, in order to picture a broader scenario, we draw a phylogenetic networks 
with STR haplotypes from all Asian families available in the lab, namely from 
Taiwanese (n=26), Japanese (n=17), Indian (n=3), Australians (aborigines; n=2), 
Chinese (n=1) and Cambodia (n=1). We obtained an unrooted phylogenetic network 
which makes difficult to infer a common ancestor. By analysing this network, we 
observer, however, the H7 haplotype from the Joseph lineage, sharing a common 
ancestor with haplotype H1. 
Figure 13: Phylogenetic network showing the most parsimonious relationships among STR-based haplotype in Taiwanese families 
belonging to Joseph (green; n=15) and Joseph-derived SNP backgrounds (blue; n=8). 
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After analysing carefully the previous network, we noticed that the source of 
genetic distance came mostly from the STR TAT223. Taking into account this is our 
most distant marker from the ATXN3-(CAG)n, we raised the hypothesis that 
recombination could be increasing unaccounted diversity in the obtained network, thus 
hampering the inference of the haplotype evolutionary direction. For this reason, we 
chose to remove the first marker (TAT223) from the STR-based haplotype to next draw 
a new phylogenetic network, reducing the effect of recombination (Figure 16). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Phylogenetic network showing the most parsimonious relationships among STR-based haplotype without TAT223 marker. 
Joseph families from Taiwan and other Asian populations are coloured in green and yellow, respectively. Joseph-derived families 
from Taiwan and other Asian populations are coloured in blue and orange, respectively. The H29 and H14 haplotypes was included 
in same circle of H23 and H6 haplotype, respectively. 
 
Figure 15: Phylogenetic network showing the most parsimonious relationships among STR-based haplotypes of Joseph Asian 
families. Joseph families from Taiwan and other Asian populations are coloured in green and yellow, respectively. Joseph-derived 
families from Taiwan and other Asian populations are coloured in blue and orange, respectively. 
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In fact, after removing the most distant marker from our STR-haplotype analysis, 
the interpretation of the network became clearer. The ancestral haplotype in Asian MJD 
populations seems to be H28, from Joseph-derived lineage (Figure 16; Supplementary 
material 5). Consequently, this lineage also displays more haplotype diversity than the 
Joseph lineage. Again, to obtain more accurate genetic distances among MJD 
backgrounds, we followed the same strategy as before, by including the SNP A/G.485 
in network analysis. Results shown in Figure 17 suggested that the origin of Joseph 
lineage is posterior to the origin of the Joseph-derived lineage in Asian populations. 
This led us to question the ancestral background in which a de novo expansion 
occurred in ATXN3 and the type of recurrent mutation at A/G.485: A>G or G>A. 
 
 
 
 
 
 
 
 
 
Figure 17: Phylogenetic network showing the most parsimonious relationships among STR haplotypes and including also the SNP 
A/G.485, without TAT223 marker. Joseph families from Taiwan and other Asian populations are coloured in green and yellow, 
respectively. Joseph-derived families from Taiwan and other Asian populations are coloured in blue and orange, respectively. The 
H29 and H14 haplotypes was included in same circle of H23 and H6 haplotype, respectively. 
 
Taking account the obtained results, we aimed to know how Asian families are 
related between them, separately, in both Joseph and Joseph derived lineages. Thus, 
we draw two phylogenetic networks with STR haplotypes, without the TAT223 marker 
and without the SNP A/G.485 (Figure 18 and Figure 19). 
 
 
 
 
Figure 18: Phylogenetic network showing the most parsimonious relationships among STR haplotypes. Joseph families from 
Taiwan and other Asian populations are coloured in green and yellow, respectively. The haplotype H14 was included in same circle 
of haplotype H6. 
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All phylogenetic networks were draw, as already referred above, based in the 
maximus parsimonious principle. Thus, the reticulation obtained in the new network 
with STR haplotypes from all Joseph-derived Asian families (Figure 19) may be 
justified due the few haplotypes analysed when compared the high number of 
haplotypes existent, once in previous network (Figure 16 and Figure 17) do not exist 
reticulations between Joseph-derived haplotypes. We obtained an unrooted 
phylogenetic network, however, the haplotype H28 seems to be the older common 
ancestral with the high number of haplotypes directly related. 
 
 
 
 
 
 
 
 
Finally, we assessed the genetic diversity among these MJD families by using the 
Arlequin software: Asian Joseph families are less diverse (0.83±0.04) while those 
carrying the G variant in the A/G.485 (0.96±0.03). Also, we used the Arlequin software 
to measure the genetic distance among all Joseph Portuguese and Asian families, and 
Joseph-derived families (Table 16). A higher genetic difference has been found 
between Portuguese and Joseph-derived families (0.67) than any other pairwise 
analysis, whereas differences were observed between Asian and Joseph-derived 
families (0.24). 
 
Table 16: Pairwise genetic distances between Asian Joseph-derived families (n=19), Asian Joseph families (n=27) and Portuguese 
Joseph families (n=40). 
Families Asian Joseph-derived  Portuguese Joseph Asian Joseph 
Asian Joseph-derived 0.00000   
Portuguese Joseph 0.66983 0.00000  
Asian Joseph 0.23657 0.26580 0.00000 
Figure 19: Phylogenetic network showing the most parsimonious relationships among STR haplotypes. Joseph-derived families 
from Taiwan and other Asian populations are coloured in blue and orange, respectively. The haplotype H29 was included in same 
circle of haplotype H23. 
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Discussion 
Genetic variation and molecular evolution can often be explained by molecular 
population genetics, which is based on population genetics principles (Casillas & 
Barbadilla 2017). 
The mutational origin of Machado-Joseph disease was initially suggested to be 
Portuguese mainly due to first descriptions among Azorean/Portuguese emigrants 
living in the United States and also to the current high number of MJD families 
diagnosed in our population. Following this scenario, it has been proposed that the 
original event occurred in mainland Portugal, spread to the Azores during its 
colonization, and from there to North and South of America, while the Portuguese 
seaman could explain its presence in Asia (Sequeiros & Coutinho 1993). Later, after 
the identification of the causative expansion in ataxin-3, molecular studies and 
population genetics principles have not supported this first idea. More accurately is a 
strategy based on the assumption that populations, places-of-birth for a given mutation, 
would have accumulated more molecular diversity on flanking regions of the respective 
disease-causing locus of interest than those where the mutation was later introduced. 
Therefore, based on this principle, a high disease frequency in a given population does 
not give us the place-of-birth for a mutation. Following this principle, an Asian 
mutational origin has been proposed for the most frequent and worldwide spread 
Joseph MJD lineage. A further analysis performed with STRs-haplotypes under the 
light of this assumption gave insight into the main spreading routes of Joseph lineage 
(Martins et al. 2007). 
As concerns Machado MJD lineage, the place-of-birth for this mutation is more 
controversial and still unclear; however, recently, our research group suggested a 
possible Portuguese origin for this lineage. Among a total of 69 Machado families 
studied (Supplementary material 6 and 7), 59 of Portuguese ancestry shared very 
similar STR-haplotypes. The remaining 10 non-Portuguese families (5 Ibero-American, 
4 North-American and one of unknown origin) showed a greater STR-haplotype 
diversity*. Following the same strategy based used for Joseph lineage, we suggested 
here an Iberian origin for the Machado MJD lineage. Moreover, based on the 
geographical distribution of families carrying this SNP background, we suggested that 
the principal route of dispersal for this mutation has been from the Iberian Peninsula to 
North and South America. 
                                                          
* Inês Costa, personal communication 
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When studying repeat-expansion disorders, the high intergenerational instability 
of their mutated alleles adds an extra difficulty to distinguish alleles identical-by-
descent (derived from a common ancestor) from alleles identical-by-state (resulted 
from independent origin events). For this reason, to trace the history of a given 
disease-associated mutation, the analysis of haplotype backgrounds associated to 
pathogenic alleles is not only useful, but an essential tool (Martins 2007). By assessing 
allelic phases of analysed flanking polymorphic markers and the expansion, one can 
avoid the overlapping of normal alleles’ evolutionary history and our expanded locus of 
interest. The inference of haplotypes segregating with the expanded allele are also of 
utmost importance to study the molecular pathway underlying repeat instability.  
Igarashi et al., in 1996, studied the intergenerational instability of the (CAG)n-
repeat in MJD. They suggested, based on study of SNP C987GG/G987GG, that an inter-
allelic interaction between normal and expanded alleles should affecting the instability 
at the ataxin-3 locus, involving probably the occurrence of gene conversion (Igarashi et 
al. 1996). Almost ten years later, gene conversion was proposed by Mittal et al. as the 
mechanism involved in the origin of a rare intermediate allele of MJD. The authors 
observed a (CAG)45 allele within the Joseph haplotype, carrying nonetheless variant at 
the sixth repeat (CAG instead of CAA), only observed in smaller alleles that were 
significantly associated with a different SNP background: the Machado MJD lineage 
(Mittal et al. 2005). Gene conversion has also been proposed to explain de novo 
generation of expanded alleles in other triplet-associated disorders, as in SCA17 
(Tomiuk et al. 2007). Also, in 2008, Martins et al. studied the influence of the MJD 
lineage on integrational instability and they raised the hypothesis of an effect of the 
haplotype background on ATXN3-(CAG)n instability in the paternal lineage. They 
observed that TTACAC (Joseph) lineage usually had a tendency for CAG expansion, 
whereas the GTGGCA (Machado) lineage was more frequently associated with 
contractions (Martins et al. 2008). In summary, this highlights the importance of 
studying the haplotype backgrounds associated to expanded alleles to search for new 
answers on different areas, such as: molecular mechanism of expansion, mutational 
origin, and disease pleomorphism. 
In this study we analysed a 4 kb region encompassing the CAG repeat of ataxin-
3, and genotyped 19 polymorphic positions which allowed to enlarge the haplotypes 
backgrounds analysed in our MJD patients: 
Machado lineage: CTAGGT (CAG)exp GCAGAGGCGGTCTGGAG; 
Joseph lineage: TCAAGC (CAG)exp CACAGAATATCTAGAGG; 
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Joseph derived lineage: TCGAGC (CAG)exp CACAGAATATCTAGAGG. 
Based on the high haplotype diversity observed in Asian populations, we 
formulated three hypotheses: 
(1) The Joseph-derived lineage (Joseph lineage with a G variant at SNP 
A/G.485) was originated by a recurrent mutation (485. A>G) on the assumed common 
Joseph haplotype background shortly after the mutational origin. This could justify the 
high haplotype diversity of this Joseph-derived lineage (0.9649±0.0276). This is in 
accordance with the reported low frequency of G allele (5%) on East Asian control 
populations; 
(2) The haplotype background with a G variant at SNP A/G.485 is more ancient 
that the Joseph lineage, thus being the most ancestral origin for MJD. In this case, the 
common Joseph lineage would have been originated by a recurrent mutation in SNP 
A/G.485 SNP (G>A), also shortly after the mutational origin. This would also explain (i) 
the high diversity of (what we named) Joseph-derived lineage, (ii) STR haplotypes from 
these lineages spread throughout the different branches of the networks, and (iii) the 
lower genetic diversity of Joseph lineage in comparison to Joseph-derived; 
(3) Both lineages underlie two different mutational origins for MJD in Asian 
populations. This hypothesis justifies high genetic diversity observed in both lineages, 
with Joseph worldwide spread and common due to genetic drift and founder effects. 
SNP genotyping data we obtained from the study of MJD origins can, in addition, 
be useful to find the best strategy to distinguish normal and expanded alleles. This 
strategy may be useful in the context of MJD therapeutics. To date, no effective 
treatment exists for ataxia. Usually, the bases of treatment of degenerative cerebellar 
ataxia are physiotherapy, occupational therapy, and speech therapy, but the level of 
success is variable for each intervention (D'Abreu & Friedman 2016). Taking into 
account the pathogenesis of MJD, considered to be caused by “gain of toxic function” 
of the expanded protein, a most effective and simple gene therapeutic approach for 
MJD requires the reduction of the mutant protein. Furthermore, given the important role 
of wild-type ATXN3 towards cell survival, the reduction of mutant ataxin-3 must be 
allele-specific, leaving wild-type protein intact. Thus, the first gene therapy suggested 
for MJD by Yi Li et al. in 2004, was the use of small interference RNA (siRNA). The 
advantage of the presence of a C variant in C987GG/G987GG SNP in linkage 
disequilibrium with the disease-causing CAG expansion (Miller et al. 2003; Li et al. 
2004) would, however, benefit MJD patients belonging to Joseph lineage. Therefore, in 
order to find the best SNPs to distinguish normal and expanded in the highest possible 
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number of MJD patients for down-regulation of expanded alleles during siRNA 
therapies, we started by searching for a polymorphic positions in which all MJD 
patients shared the same allele status in cis with the expansion. Taking this into 
account, we highlighted the SNPs rs10467857 (C/G.910). For this polymorphic position 
fifty-five MJD patients were genotyped, and in all heterozygous patients (thirty-seven), 
the G variant was always associated with the expanded allele. Furthermore, we did not 
find any patient that be homozygous for allele C (i.e., none MJD patients from our 
cohorts had the genotype C/C at C/G.910). We performed this same analysis in two 
other polymorphic positions flanking the MJD repeat: rs2006047 (A/G.3645) and 
rs7142326 (A/G.3912). In any of our Taiwanese or Portuguese patients, we found the 
A/A for A/G.3645 or A/G.3912 (Supplementary material 1 and 2); simultaneously, by 
analysing our PHASE results (Supplementary material 3 and 4), the G allele of both 
SNPs was always associated with expanded allele. Also, in a previous study, it is 
described that none of these SNPs distinguish Machado and Joseph lineages, with the 
G nucleotide always observed to segregate with the expanded alleles (Martins et al. 
2012)†. By analysing all 19 described alternative ATXN3 transcripts, however, none of 
these 3 SNPs (rs10467857, rs2006047 and rs71423226) is located within transcribed 
regions. This way, our strategy should be further applied to search for other (CAG)n 
flanking variants known to be transcribed in humans. 
  
                                                          
† Sandra Martins, personal communication 
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Conclusions and Future perspectives 
Under a haplotype-based approach, this study focused on four specific goals that 
were mostly achieved: 
(1) we optimized 5 PCRs that allowed the inference of allelic phases of expanded 
MJD alleles;  
(2) we identified 19 SNPs flanking the (CAG)n-ATXN3 that distinguish the two 
main MJD lineages identified so far: Machado and Joseph;  
(3) we suggested 3 SNPs to distinguish normal and expanded alleles in MJD 
patients from different lineages; and 
(4) we raised the hypothesis of another de novo mutational origin for Machado-
Joseph disease to explain the high genetic diversity in a third observed MJD SNP-
background. 
Next, to emphasise and clarify the obtained results and to validate our findings, 
future work may include: 
(i) the increasement of the number of Asian samples as well the number of 
populations to analyse in order to find new MJD lineages; 
(ii) the optimization of a single 4 kb PCR with allele-specific on different SNPs to 
achieve more accurately the allelic phases of expanded MJD alleles, and; 
(iii) the increasement of the number of haplotypes obtained by familiar 
segregation, diminishing, consequently, the need of inferring allelic phases through 
informatics tools. Thus, it would be necessary to assess a higher number of relatives in 
cases of isolated MJD patients, to verify the existence of possibly informative non-
affected relatives. 
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Supplementary material 1: Genotyping data of SNPs found in Portuguese MJD families. 
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U4215 P10 
      
G/C C/A A/C G/A A/G A/G G/A C/T G/A G/T T/C C/T T/A A/G G/A G/G A/G 
U4455 P52 C/C T/T A/A G/G C/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G 
   
A/G G/G G/A A/G 
U4459 P57 C/C T/T A/A G/G C/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G 
   
A/G G/G G/A A/G 
U4485 P63 C/C T/T A/A G/G C/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G T/T C/C T/T A/G G/G G/A A/G 
U4483 P63 C/T T/C A/A G/A G/G T/C G/C C/A A/C A/G A/G G/A G/A C/T G/A G/T 
   
G/G 
   
U1722 P67 C/C T/T A/A G/G G/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G 
  
T/T A/G G/G G/A A/G 
U484 P72 C/C T/T A/A G/G C/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G T/T C/C T/T A/G G/G G/A A/G 
U2402 P83 
        
A/A G/G A/A G/G G/G C/C G/G G/G 
       
U5816 P83 C/C T/T A/A 
 
C/G T/T 
                 
U3196 P91 C/T 
 
A/A G/A C/G T/C G/C C/A A/C 
 
A/G G/A G/A C/T G/A G/T 
       
U3301 P96 
                
T/C T/C T/A A/G A/G G/G A/G 
U3302 P96 C/T T/C A/A G/A C/G C/T G/C C/A A/C A/G A/G A/G A/G C/T G/A G/T 
     
G/G 
 
U4121 P96 
                
C/C T/T A/A G/G A/A G/G G/G 
U1419 P97 C/C T/T A/A G/G C/G T/T G/G C/C A/A 
 
A/A G/G G/G C/C G/G G/G T/T C/C T/T A/G G/G G/A A/G 
U1548 P99 C/T T/C A/A G/A C/G T/C G/C C/A A/C 
 
A/G G/A G/A C/T G/A G/T 
       
U6178 P110 C/C T/T A/A G/G C/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G 
  
T/T A/G G/G G/A 
 
U3911 P110 
   
G/G C/G T/T 
 
C/C A/A G/G A/A G/G G/G C/C G/G G/G 
  
T/T A/G G/G G/A 
 
U5993 P111 C/T T/C A/A G/A G/G T/C G/C C/A A/C A/G A/G G/A G/A C/T G/A G/T 
   
G/G G/A G/A G/G 
U7830 P112 C/T 
 
A/A G/A G/G T/C G/C C/A A/C A/G A/G G/A G/A C/T G/A G/T 
   
G/G G/A G/G G/G 
U6280 P114 C/C T/T A/A G/G G/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G 
       
U7901 P117 C/T 
 
A/A G/A C/G 
 
G/C C/A C/A A/G A/G G/A G/A C/T G/A G/T 
       
U6262 P117 C/T T/C A/A G/A C/G T/C G/C C/A C/A A/G A/G G/A G/A C/T G/A G/T 
   
A/G G/A G/G A/G 
U7284 N12 C/T T/C A/A G/A C/G T/C G/C C/A A/C A/G A/G G/A G/A C/T G/A G/T 
   
A/G G/A G/G A/G 
U6384 N12 C/T T/C A/A G/A C/G T/C G/C C/A A/C A/G A/G G/A G/A C/T G/A G/T C/T C/T T/A A/G G/A G/G A/G 
U7874 N13 C/C T/T A/A G/G C/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G 
       
U7628 N13 C/C T/T A/A G/G C/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G 
   
A/G G/G G/A 
 
U7933 N14 C/C T/T A/A G/G C/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G 
   
A/G G/G G/A 
 
U7431 N15 C/C T/T A/A G/G C/G T/T G/G C/C A/A G/G A/A G/G G/G C/C G/G G/G 
  
T/T 
    
U12201 N19 T/T C/C A/A A/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T 
       
X - underline nucleotides are associated to normal allele 
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Supplementary material 2: Genotyping data of SNPs found in Taiwanese MJD families. 
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1 S1 C/T T/C A/G G/A C/G T/C G/C C/A C/A A/G A/G G/A G/A C/T G/A G/T 
   
A/G G/A G/G A/G 
3 S1 T/T C/C A/G 
   
C/C A/A C/C 
        
T/T A/A 
    
4 S2 T/T C/C A/A A/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T C/C T/T A/A G/G A/A G/G G/G 
1 S3 T/T C/C A/A A/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T C/C T/T A/A G/G A/A G/G G/G 
3 S3 C/T T/C A/A G/A C/G T/C G/C 
 
A/C A/G A/G G/A G/A C/T G/A G/T T/C C/T T/A A/G A/G G/G A/G 
6 S4 T/T C/C A/G A/A G/G C/C C/C A/A C/C 
       
C/C T/T A/A G/G A/A G/G G/G 
2 S5 T/T C/C A/A A/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T 
   
G/G A/A G/G G/G 
1 S5 T/T C/T A/A G/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T 
       
2 S6 C/T T/C A/G G/A C/G T/C G/C C/A A/C A/G A/G G/A G/A C/T G/A G/T T/C C/T T/A A/G A/G G/G A/G 
3 S7 C/T T/C A/A G/A C/G T/C G/C C/A A/C A/G A/G G/A G/A C/T G/A G/T T/C C/T T/A A/G G/A G/G A/G 
2 S8 
 
C/C A/A A/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T 
       
5 S8 C/T T/C A/A G/A C/G T/C G/C C/A A/C 
 
A/G G/A G/A C/T G/A G/T T/C C/T T/A A/G G/A G/G A/G 
3 S9 T/T C/T A/A A/A G/G C/C G/C A/C A/C A/G A/G G/A A/G C/T A/G G/T C/C T/T A/A G/G A/A G/G G/G 
1 S10 C/T T/C A/A G/A C/G T/C G/C C/A C/C 
 
A/G G/A G/A C/T G/A G/T T/C C/T T/A A/G G/A G/G A/G 
3 S10 T/T C/C A/A A/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T 
       
1 S12 T/T C/C A/G A/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T 
   
G/G A/A G/G A/G 
2 S12 T/T 
 
A/G A/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T 
   
G/G A/A G/G G/G 
4 S12 T/C T/C A/G G/A G/C C/T G/C C/A A/C 
              
1 S13 T/T C/C A/A A/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T C/C T/T A/A 
 
A/A G/G G/G 
2 S15 
  
A/A G/A C/G T/C 
  
A/C A/G A/G G/A G/A C/T G/A G/T T/C C/T T/A 
    
1 S15 C/T T/C A/A 
                    
1 S17 C/T T/C A/G 
   
G/C C/A A/C 
              
2 S17 C/T 
 
A/G G/A C/G T/C G/C C/A C/A A/G 
      
T/C C/T T/A A/G G/A G/G A/G 
1 S18 C/T T/C A/G G/A C/G T/C 
 
C/A A/C G/A A/G G/A G/A C/T G/A G/T 
       
2 S18 C/T T/C A/G G/A C/G T/C G/C C/A A/C G/A 
      
T/C C/T T/A A/G G/A G/G A/G 
1 S19 
         
A/A G/G A/A A/A T/T A/A T/T C/C T/T A/A G/G A/A G/G G/G 
3 S19 C/T T/C A/A G/A C/G T/C G/C C/A C/A A/G A/G G/A G/A C/T G/A G/T 
   
A/G G/A G/G 
 
3 S20 C/T T/C A/A G/A C/G T/C G/C C/A C/A 
 
A/G G/A G/A C/T G/A G/T 
   
A/G G/A G/G A/G 
1 S21 T/T C/C A/A 
   
C/C A/A C/C 
              
3 S21 C/T T/C A/A G/A C/G T/C G/C C/A 
         
C/T T/A A/G G/A G/G A/G 
1 S22 C/T T/C A/A G/A C/G T/C G/C C/A A/C A/G A/G G/A G/A C/T G/A G/T 
   
A/G G/A G/G A/G 
2 S22 
      
G/C C/A 
           
G/G A/A G/G G/G 
1 S23 T/T C/C A/A A/A G/G C/C 
  
C/C A/A G/G A/A A/A T/T A/A T/T C/C T/T A/A G/G A/A G/G G/G 
2 S23 
 
C/C A/A A/A G/G C/C C/C A/A C/C A/A G/G A/A A/A T/T A/A T/T C/C T/T A/A G/G A/A G/G G/G 
3 S24 C/T T/C A/G G/A C/G T/C G/C C/A A/C 
 
A/G G/A G/A C/T G/A G/T T/C C/T T/A A/G G/A G/G A/G 
1 S25 C/T T/C A/A G/A C/G T/C G/C C/A 
  
A/G G/A G/A C/T G/A G/T 
   
A/G 
   
2 S25 C/T T/C A/A G/A C/G T/C G/C C/A C/A 
 
A/G G/A G/A C/T G/A G/T T/C C/T T/A A/G G/A G/G A/G 
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X - underline nucleotides are associated to normal allele 
Supplementary material 3: Haplotypes inferred for Portuguese MJD families based on allele-specific amplification, family segregation or PHASE software. 
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P52 C T A G G T G C A G A G G C G G T C T G G A G 0.930 
P57 C T A G G T G C A G A G G C G G T C T G G A G 0.909 
P63 C T A G G T G C A G A G G C G G T C T G G A G 0.999 
P67 C T A G G T G C A G A G G C G G T C T G G A G 0.913 
P72 C T A G G T G C A G A G G C G G T C T G G A G 0.996 
P83/P57# C T A 
  
T 
  
A G A G G C G G 
       
 
P97 C T A G G T G C A G A G G C G G T C T G G A G 0.988 
P110 C T A G G T G C A G A G G C G G T C T G G A G 0.912 
P111 C T A G G T G C A G A G G C G G T C T G G A G 0.917 
P114 C T A G G T G C A G A G G C G G T C T G G A G 0.601 
N13 C T A G G T G C A G A G G C G G T C T G G A G 0.910 
N14 C T A G G T G C A G A G G C G G T C T G G A G 0.919 
N15 C T A G G T G C A G A G G C G G T C T G G A G 0.602 
Joseph families 
                       
 
P10 T C A A G C C A C A G A A T A T C T A G A G G 0.862 
P96 T C A A G C C A C A G A A T A T C T A G A G G 0.957 
P91 T C A A G C C A C A G A A T A T C T A G A G G 0.886 
P112 T C A A G C C A C A G A A T A T C T A G A G G 0.895 
P117 T C A A G C C A C A G A A T A T C T A G A G G 0.915 
N12 T C A A G C C A C A G A A T A T C T A G A G G 1.000 
N19 T C A A G C C A C A G A A T A T C T A G A G G 0.917 
P99 T C A A G C C A C A G A A T A T C T A G A G G 0.870 
Note: The nucleotides in black represents the phase obtained from Phase software. 
a Probabilities for the haplotypes reconstructed by PHASE 2.2. 
# We were not able to infer the SNP haplotypes with PHASE 2.2 from P83 family; however the STR markers, previously analysed, showed that both P83 and P57 families have the same STR haplotype. 
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Supplementary material 4: Haplotypes inferred for Taiwanese MJD families based on allele-specific amplification, family segregation or PHASE software. 
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S1 T C G A G C C A C A G A A T A T C T A G A G G 0.956 
S2 T C A A G C C A C A G A A T A T C T A G A G G 1.000 
S3 T C A A G C C A C A G A A T A T C T A G A G G 0.995 
S4 T C G A G C C A C A G A A T A T C T A G A G G 0.947 
S5 T T G A G C C A C A G A A T A T C T A G A G G 0.759 
S6 T C G A G C C A C A G A A T A T C T A G A G G 1.000 
S7 T C A A G C C A C A G A A T A T C T A G A G G 0.999 
S8 T C A A G C C A C A G A A T A T C T A G A G G 0.986 
S9 T T A A G C C A C A G A A T A T C T A G A G G 0.835 
S10 T C A A G C C A C A G A A T A T C T A G A G G 0.983 
S12 T C G A G C C A C A G A A T A T C T A G A G G 0.958 
S13 T C A A G C C A C A G A A T A T C T A G A G G 0.987 
S15 T C A A G C C A C A G A A T A T C T A G A G G 0.892 
S17 T C G A G C C A C A G A A T A T C T A G A G G 0.955 
S18 T C G A G C C A C A G A A T A T C T A G A G G 0.948 
S19 T C A A G C C A C A G A A T A T C T A G A G G 0.948 
S20 T C A A G C C A C A G A A T A T C T A G A G G 0.962 
S21 T C A A G C C A C A G A A T A T C T A G A G G 0.879 
S22 T C A A G C C A C A G A A T A T C T A G A G G 0.966 
S23 T C A A G C C A C A G A A T A T C T A G A G G 0.998 
S24 T C G A G C C A C A G A A T A T C T A G A G G 0.981 
S25 T C A A G C C A C A G A A T A T C T A G A G G 0.988 
Note: The nucleotides in black represents the phase obtained from Phase software 
a  Probabilities for the haplotypes reconstructed by PHASE 2.2. 
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Supplementary material 5: STR-haplotype, previously obtaneid, for Asian MJD families from the Joseph lineage. 
Haplotype 
Number 
of families 
TAT223 GT199 ATA194 AC21 AAAC123 GT190 AC190 
Asian haplotypes with A allele 
at A/G.485 
 
H1 1 17 23 10 14 8 19 23 
H6 5 16 25 10 14 5 15 24 
H7 1 16 25 10 14 5 19 24 
H9 2 11 24 10 14 5 14 24 
H11 1 11 21 9 14 5 15 24 
H12 8 10 21 10 13 7 15 24 
H14 1 10 25 10 14 5 15 24 
H15 1 10 21 11 13 7 15 24 
H17 7 8 22 10 14 8 19 23 
Asian haplotypes with G allele 
at A/G.485 
 
H19 1 17 23 10 13 7 19 28 
H20 1 16 23 9 12 7 19 26 
H21 2 16 23 9 12 8 15 24 
H22 1 16 20 11 14 8 19 25 
H23 1 16 21 10 14 5 19 25 
H24 3 14 23 10 12 8 19 25 
H25 1 10 24 9 18 7 19 26 
H26 1 10 25 10 12 7 19 25 
H27 1 10 23 13 12 7 19 24 
H28 2 10 23 10 12 7 19 25 
H29 1 10 21 10 14 5 19 25 
H8 2 15 23 9 12 7 19 25 
H10 1 11 22 10 12 7 16 26 
H3 1 16 23 9 12 8 15 25 
Portuguese haplotypes  
H31 38 11 21 11 14 5 15 25 
H32 2 17 21 10 14 5 15 24 
 
 
64 |Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds 
 
 Portuguese and Taiwanese Machado-Joseph disease haplotype backgrounds| 65 
 
Supplementary material 6: STR-haplotype, previously obtained, for worldwide MJD families from Machado lineage 
Haplotype 
Number of 
families 
TAT223 GT199 ATA194 AC21 AAAC123 GT190 AC190 
Portuguese   
H33 1 16 23 9 18 7 19 24 
H34 40 10 20 10 18 7 19 24 
H35 9 16 25 10 18 7 19 24 
H36 5 17 25 10 18 7 19 24 
H37 3 11 24 9 18 7 19 24 
H38 1 17 25 10 19 7 19 24 
Spanish   
H39 2 10 20 10 18 7 15 24 
Peruvians   
H40 2 11 21 11 14 7 19 28 
Caribbean          
H41 1 16 22/26 10 14 8 19 25/27 
North American   
H42 1 16 25 10 18 7 19 24 
H43 1 10/11 19/21 10/13 14/18 7 19 24/28 
H44 2 15 17 7 14 7 18 24 
Unkonwn  
H45 1 11 21 11 14 7 18 28 
Note: Underlined haplotypes were not used to reconstruct the phylogenetic network 
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Supplementary material 7: Phylogenetic network showing the most parsimonious relationships among STR-based haplotypes of all 
Machado MJD families. Families from Portugal (n=59) are coloured in yellow. Families from Spain (n=2), Peru (n=2), North-
American (n=3) and from unknown origin (n=1) are coloured in pink, green, blue and black, respectively. The haplotype H42 was 
included in the same circle as haplotype H35. 
